Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Saxagliptin is a new investigational medication being developed for treatment of type 2
diabetes. This study is designed to test the efficacy of once daily saxagliptin in renally
impaired patients.